Gamida Cell Ltd.
GMDADelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001600847
Gamida Cell Ltd. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 52 institutions reported holding it in 13F filings for Q1 2024, worth $697.9K in total; ARK Invest was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Gamida Cell Ltd. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 73 | 1 | 63 | −9 |
| Shares | 21.6M | 100.0K | 18.0M | −3.50M (−16.3%) |
| Value | $84.8M | $392.0K | $45.8M | −$38.6M (−45.7%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Gamida Cell Ltd. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Highbridge Capital Management LLC | 797,544 | $2.03M | 0.05% |
| Levin Capital Strategies, L.P. | 70,000 | $178.0K | 0.02% |
| Spire Wealth Management | 55,125 | $140.0K | 0.00% |
| Gsa Capital Partners LLP | 32,548 | $83.0K | 0.01% |
| Group One Trading, L.P. | 22,410 | $57.0K | 0.00% |
| Stifel Financial Corp | 14,431 | $37.0K | 0.00% |
| Engineers Gate Manager LP | 12,555 | $32.0K | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 1,429 | $4.00K | 0.00% |
| Rockefeller Capital Management L.P. | 35 | $0 | 0.00% |
Sold out (18)
Institutions that held Gamida Cell Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Stonepine Capital Management, LLC | 1,724,201 | $6.76M |
| Altshuler Shaham Ltd | 499,468 | $1.97M |
| Millennium Management LLC | 146,235 | $573.0K |
| Tekla Capital Management LLC | 118,142 | $463.0K |
| Alps Advisors Inc | 72,646 | $285.0K |
| Walleye Capital LLC | 41,171 | $161.0K |
| Trexquant Investment LP | 40,709 | $160.0K |
| Jane Street Group, LLC | 36,465 | $143.0K |
| Cubist Systematic Strategies, LLC | 33,523 | $131.0K |
| Virtus ETF Advisers LLC | 33,121 | $130.0K |
| Jump Financial, LLC | 23,400 | $92.0K |
| UBS Group AG | 13,861 | $54.0K |
| ProShare Advisors LLC | 12,663 | $50.0K |
| Premier Asset Management LLC | 12,788 | $50.0K |
| Walleye Trading LLC | 12,157 | $48.0K |
| Bank of New York Mellon Corp | 10,000 | $39.0K |
| Penserra Capital Management LLC | 1,350 | $5.00K |
| Barclays PLC | 6 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Gamida Cell Ltd. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $392.0K |